Targeting α‐Synuclein: A Further Viewpoint

Movement DisordersVolume 38, Issue 4 p. 715-716 Letters: Published Articles Targeting α-Synuclein: A Further Viewpoint Anthony E. Lang MD, FRCPC, Corresponding Author Anthony E. Lang MD, FRCPC [email protected] orcid.org/0000-0003-1229-3667 Edmond J. Safra Program in Parkinson's Disease, University Health Network and the University of Toronto, Toronto, Ontario, Canada Correspondence to: Anthony E. Lang, Edmond J. Safra Program in Parkinson's Disease, University Health Network and the University of Toronto University Health Network and the University of Toronto, 399 Bathurst St, MC 7-412, Toronto, Ontario M5T 2S8, Canada; E-mail: [email protected]Search for more papers by this author Anthony E. Lang MD, FRCPC, Corresponding Author Anthony E. Lang MD, FRCPC [email protected] orcid.org/0000-0003-1229-3667 Edmond J. Safra Program in Parkinson's Disease, University Health Network and the University of Toronto, Toronto, Ontario, Canada Correspondence to: Anthony E. Lang, Edmond J. Safra Program in Parkinson's Disease, University Health Network and the University of Toronto University Health Network and the University of Toronto, 399 Bathurst St, MC 7-412, Toronto, Ontario M5T 2S8, Canada; E-mail: [email protected]Search for more papers by this author First published: 16 April 2023 https://doi.org/10.1002/mds.29345 Relevant conflicts of interest/financial disclosures: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume38, Issue4April 2023Pages 715-716 RelatedInformation